Literature DB >> 34365971

Factors influencing the detection of treatable epileptogenic lesions on MRI. A randomized prospective study.

Tim Wehner1, Philippe Weckesser1, Steven Schulz1, Annika Kowoll2, Sebastian Fischer2, Jessica Bosch1, Leonie Weinhold3, Rolf Fimmers3, Matthias Schmid3, Jörg Wellmer4.   

Abstract

BACKGROUND: To prospectively analyze factors associated with detecting epileptogenic lesions on MRI within the work-sharing process of neurologists, epileptologists, radiologists and neuroradiologists.
METHODS: We assembled four sets of six MRI scans, each set representing five typical epileptogenic lesions (hippocampal sclerosis or limbic encephalitis; focal cortical dysplasias; periventricular nodular or other heterotopias; long-term epilepsy associated tumors; gliotic scar, hemosiderin or cavernoma), and non - lesional epilepsy. At professional conferences, we invited neurologists, epileptologists, radiologists, and neuroradiologists to read two out of four MRI sets, one of which was presented with a clinical focus hypothesis. Participants were randomly assigned to MRI sets. Effects of examiners' specialty, duration of training and professional experience on detection rate of epileptogenic lesions were investigated.
RESULTS: Fourty-eight neurologists, 22 epileptologists, 20 radiologists and 21 neuroradiologists read 1323 MRI scans. Overall, 613 of 1101 (55.7%) epileptogenic lesions were detected. Long-term epilepsy associated tumors (182/221, 82.4%) were found more frequently than gliotic scar, hemosiderin or cavernoma (157/220, 71.4%), hippocampal sclerosis or limbic encephalitis (141/220, 64.1%), nodular heterotopia (68/220, 30.9%) and focal cortical dysplasias (65/220, 29.5%, p < 0.001). Provision of a focus hypothesis improved the detection of hippocampal sclerosis or limbic encephalitis (86/110, 78.2% vs 55/110, 50%, p < 0.001) and focal cortical dysplasias (40/110, 36.4% vs 25/110, 22.7%, p = 0.037). Neuroradiologists and epileptologists were more likely than radiologists and neurologists to be amongst the most successful readers. In multivariable analysis, type of epileptogenic lesion, specialty of MRI reader, and provision of focus hypothesis predicted correct identification of epileptogenic lesions.
CONCLUSIONS: Epileptogenic lesions are often not recognized on MRI even by expert readers. Their detection can be improved by providing a focus hypothesis. These results stress the need for training in the MRI characteristics of epilepsy - specific pathology, and, most importantly, interdisciplinary communication between neurologists/epileptologists and (neuro)radiologists to improve detection of epileptogenic lesions.
© 2021. The Author(s).

Entities:  

Keywords:  Focal cortical dysplasia; Gliotic scar; Hippocampal sclerosis; Limbic encephalitis; Low grade epilepsy associated tumor; Nodular heterotopia

Year:  2021        PMID: 34365971     DOI: 10.1186/s42466-021-00142-z

Source DB:  PubMed          Journal:  Neurol Res Pract        ISSN: 2524-3489


  9 in total

Review 1.  Neuroimaging of epilepsy.

Authors:  Fernando Cendes; William H Theodore; Benjamin H Brinkmann; Vlastimil Sulc; Gregory D Cascino
Journal:  Handb Clin Neurol       Date:  2016

Review 2.  Recommendations for the use of structural magnetic resonance imaging in the care of patients with epilepsy: A consensus report from the International League Against Epilepsy Neuroimaging Task Force.

Authors:  Andrea Bernasconi; Fernando Cendes; William H Theodore; Ravnoor S Gill; Matthias J Koepp; Robert Edward Hogan; Graeme D Jackson; Paolo Federico; Angelo Labate; Anna Elisabetta Vaudano; Ingmar Blümcke; Philippe Ryvlin; Neda Bernasconi
Journal:  Epilepsia       Date:  2019-05-28       Impact factor: 5.864

Review 3.  Autoimmune epilepsy: findings on MRI and FDG-PET.

Authors:  Julie Guerin; Robert E Watson; Carrie M Carr; Greta B Liebo; Amy L Kotsenas
Journal:  Br J Radiol       Date:  2018-09-20       Impact factor: 3.039

4.  Proposal for a magnetic resonance imaging protocol for the detection of epileptogenic lesions at early outpatient stages.

Authors:  Jörg Wellmer; Carlos M Quesada; Lars Rothe; Christian E Elger; Christian G Bien; Horst Urbach
Journal:  Epilepsia       Date:  2013-10-07       Impact factor: 5.864

Review 5.  Brain imaging in the assessment for epilepsy surgery.

Authors:  John S Duncan; Gavin P Winston; Matthias J Koepp; Sebastien Ourselin
Journal:  Lancet Neurol       Date:  2016-02-24       Impact factor: 44.182

6.  Failure of standard magnetic resonance imaging in patients with refractory temporal lobe epilepsy.

Authors:  M C McBride; K S Bronstein; B Bennett; G Erba; W Pilcher; M J Berg
Journal:  Arch Neurol       Date:  1998-03

7.  Usefulness of repeat review of head magnetic resonance images during presurgical epilepsy conferences.

Authors:  Daniel L Kenney; Kristen M Kelly-Williams; Karl N Krecke; Robert J Witte; Robert E Watson; Amy L Kotsenas; Elaine C Wirrell; Katherine C Nickels; Lily C Wong-Kisiel; Elson So
Journal:  Epilepsy Res       Date:  2016-07-01       Impact factor: 3.045

Review 8.  MRI in epilepsy: clinical standard and evolution.

Authors:  Theodor Rüber; Bastian David; Christian E Elger
Journal:  Curr Opin Neurol       Date:  2018-04       Impact factor: 5.710

Review 9.  ILAE official report: a practical clinical definition of epilepsy.

Authors:  Robert S Fisher; Carlos Acevedo; Alexis Arzimanoglou; Alicia Bogacz; J Helen Cross; Christian E Elger; Jerome Engel; Lars Forsgren; Jacqueline A French; Mike Glynn; Dale C Hesdorffer; B I Lee; Gary W Mathern; Solomon L Moshé; Emilio Perucca; Ingrid E Scheffer; Torbjörn Tomson; Masako Watanabe; Samuel Wiebe
Journal:  Epilepsia       Date:  2014-04-14       Impact factor: 5.864

  9 in total
  1 in total

1.  Brain magnetic resonance imaging findings among children with epilepsy in two urban hospital settings, Kampala-Uganda: a descriptive study.

Authors:  Denise Apolot; Geoffrey Erem; Rita Nassanga; Daniel Kiggundu; Crescent Max Tumusiime; Anneth Teu; Alex Mwesigwa Mugisha; Robert Sebunya
Journal:  BMC Med Imaging       Date:  2022-10-06       Impact factor: 2.795

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.